vs
华美银行集团（EWBC）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是华美银行集团的1.8倍（$1.4B vs $775.0M），华美银行集团净利率更高（46.2% vs 27.6%，领先18.6%），瑞思迈同比增速更快（11.0% vs 2.1%），过去两年华美银行集团的营收复合增速更高（18.4% vs 9.0%）
华美银行集团旗下核心子公司为华美银行，是总部位于美国南加州的最大上市银行控股集团。集团资产规模超100亿美元，曾获评标普全球市场财智全美最佳银行，自2023年起连续三年位列《银行董事》杂志同资产规模银行绩效榜单首位。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
EWBC vs RMD — 直观对比
营收规模更大
RMD
是对方的1.8倍
$775.0M
营收增速更快
RMD
高出8.9%
2.1%
净利率更高
EWBC
高出18.6%
27.6%
两年增速更快
EWBC
近两年复合增速
9.0%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $775.0M | $1.4B |
| 净利润 | $358.0M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | — | 34.6% |
| 净利率 | 46.2% | 27.6% |
| 营收同比 | 2.1% | 11.0% |
| 净利润同比 | 0.4% | 13.9% |
| 每股收益（稀释后） | $2.57 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWBCRMD
| Q1 26 | $775.0M | — | ||
| Q4 25 | $657.8M | $1.4B | ||
| Q3 25 | $677.5M | $1.3B | ||
| Q2 25 | $617.1M | $1.3B | ||
| Q1 25 | $600.2M | $1.3B | ||
| Q4 24 | $587.6M | $1.3B | ||
| Q3 24 | $572.7M | $1.2B | ||
| Q2 24 | $553.2M | $1.2B |
净利润EWBCRMD
| Q1 26 | $358.0M | — | ||
| Q4 25 | $356.3M | $392.6M | ||
| Q3 25 | $368.4M | $348.5M | ||
| Q2 25 | $310.3M | $379.7M | ||
| Q1 25 | $290.3M | $365.0M | ||
| Q4 24 | $293.1M | $344.6M | ||
| Q3 24 | $299.2M | $311.4M | ||
| Q2 24 | $288.2M | $292.2M |
毛利率EWBCRMD
| Q1 26 | — | — | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% |
营业利润率EWBCRMD
| Q1 26 | — | — | ||
| Q4 25 | 71.0% | 34.6% | ||
| Q3 25 | 68.6% | 33.4% | ||
| Q2 25 | 65.2% | 33.7% | ||
| Q1 25 | 65.2% | 33.0% | ||
| Q4 24 | 60.6% | 32.5% | ||
| Q3 24 | 68.0% | 31.6% | ||
| Q2 24 | 65.9% | 31.2% |
净利率EWBCRMD
| Q1 26 | 46.2% | — | ||
| Q4 25 | 54.2% | 27.6% | ||
| Q3 25 | 54.4% | 26.1% | ||
| Q2 25 | 50.3% | 28.2% | ||
| Q1 25 | 48.4% | 28.3% | ||
| Q4 24 | 49.9% | 26.9% | ||
| Q3 24 | 52.2% | 25.4% | ||
| Q2 24 | 52.1% | 23.9% |
每股收益（稀释后）EWBCRMD
| Q1 26 | $2.57 | — | ||
| Q4 25 | $2.55 | $2.68 | ||
| Q3 25 | $2.65 | $2.37 | ||
| Q2 25 | $2.24 | $2.58 | ||
| Q1 25 | $2.08 | $2.48 | ||
| Q4 24 | $2.10 | $2.34 | ||
| Q3 24 | $2.14 | $2.11 | ||
| Q2 24 | $2.06 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $9.0B | $6.3B |
| 总资产 | $82.9B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资EWBCRMD
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $1.4B | ||
| Q3 25 | $4.7B | $1.4B | ||
| Q2 25 | $4.4B | $1.2B | ||
| Q1 25 | $3.4B | $932.7M | ||
| Q4 24 | $5.3B | $521.9M | ||
| Q3 24 | $4.9B | $426.4M | ||
| Q2 24 | $4.4B | $238.4M |
总债务EWBCRMD
| Q1 26 | — | — | ||
| Q4 25 | $35.6M | $403.9M | ||
| Q3 25 | $35.7M | $408.7M | ||
| Q2 25 | $35.8M | $658.4M | ||
| Q1 25 | $35.9M | $663.1M | ||
| Q4 24 | $36.0M | $662.9M | ||
| Q3 24 | $36.1M | $667.6M | ||
| Q2 24 | $36.1M | $697.3M |
股东权益EWBCRMD
| Q1 26 | $9.0B | — | ||
| Q4 25 | $8.9B | $6.3B | ||
| Q3 25 | $8.6B | $6.1B | ||
| Q2 25 | $8.2B | $6.0B | ||
| Q1 25 | $7.9B | $5.5B | ||
| Q4 24 | $7.7B | $5.3B | ||
| Q3 24 | $7.7B | $5.2B | ||
| Q2 24 | $7.2B | $4.9B |
总资产EWBCRMD
| Q1 26 | $82.9B | — | ||
| Q4 25 | $80.4B | $8.5B | ||
| Q3 25 | $79.7B | $8.3B | ||
| Q2 25 | $78.2B | $8.2B | ||
| Q1 25 | $76.2B | $7.6B | ||
| Q4 24 | $76.0B | $7.1B | ||
| Q3 24 | $74.5B | $7.2B | ||
| Q2 24 | $72.5B | $6.9B |
负债/权益比EWBCRMD
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | 0.06× | ||
| Q3 25 | 0.00× | 0.07× | ||
| Q2 25 | 0.00× | 0.11× | ||
| Q1 25 | 0.00× | 0.12× | ||
| Q4 24 | 0.00× | 0.13× | ||
| Q3 24 | 0.00× | 0.13× | ||
| Q2 24 | 0.01× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $339.7M |
| 自由现金流经营现金流 - 资本支出 | — | $311.2M |
| 自由现金流率自由现金流/营收 | — | 21.9% |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流EWBCRMD
| Q1 26 | — | — | ||
| Q4 25 | $713.4M | $339.7M | ||
| Q3 25 | $231.7M | $457.3M | ||
| Q2 25 | $278.7M | $538.8M | ||
| Q1 25 | $277.9M | $578.7M | ||
| Q4 24 | $500.1M | $308.6M | ||
| Q3 24 | $386.1M | $325.5M | ||
| Q2 24 | $259.2M | $440.1M |
自由现金流EWBCRMD
| Q1 26 | — | — | ||
| Q4 25 | — | $311.2M | ||
| Q3 25 | — | $414.4M | ||
| Q2 25 | — | $508.2M | ||
| Q1 25 | — | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | — | $307.7M | ||
| Q2 24 | — | $415.2M |
自由现金流率EWBCRMD
| Q1 26 | — | — | ||
| Q4 25 | — | 21.9% | ||
| Q3 25 | — | 31.0% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 33.9% |
资本支出强度EWBCRMD
| Q1 26 | — | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.0% |
现金转化率EWBCRMD
| Q1 26 | — | — | ||
| Q4 25 | 2.00× | 0.87× | ||
| Q3 25 | 0.63× | 1.31× | ||
| Q2 25 | 0.90× | 1.42× | ||
| Q1 25 | 0.96× | 1.59× | ||
| Q4 24 | 1.71× | 0.90× | ||
| Q3 24 | 1.29× | 1.05× | ||
| Q2 24 | 0.90× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EWBC
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
